Search results for "Deoxyglucose"

showing 10 items of 93 documents

Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired In…

2017

Hippocampal atrophy and hypometabolism of the posterior cingulate cortex (PCC), early markers of Alzheimer's disease (AD), have been shown to be associated in late mild cognitive impairment and early AD via atrophy of connecting cingulum fibers. Recently, a direct association of hippocampal atrophy and PCC hypometabolism has been shown in cognitively normal elderly. We aimed to investigate if this association might be modulated by partly non-hippocampogenic alterations of parahippocampal cingulum (PHC) integrity. 45 cognitively healthy elderly aged 59 to 89 years were included from the Alzheimer's Disease Neuroimaging Initiative. Hippocampal volumes and PCC glucose metabolism were measured …

MaleAgingeducationHippocampusHippocampal formationbehavioral disciplines and activitiesBrain mappingGyrus CinguliHippocampus030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAtrophyFluorodeoxyglucose F18medicineCingulum (brain)HumansGray MatterDiaschisisAgedAged 80 and overBrain Mappingbusiness.industryGeneral NeuroscienceGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureGlucosePosterior cingulatePositron-Emission TomographyParahippocampal GyrusRegression AnalysisFemaleGeriatrics and GerontologyAtrophyRadiopharmaceuticalsbusinessNeuroscience030217 neurology & neurosurgeryParahippocampal gyrusJournal of Alzheimer's disease : JAD
researchProduct

Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease

2004

The present study examined the cortical functional representation of neuropsychological domains in Alzheimer's disease (AD) using positron emission tomography (PET) and the neuropsychological assessment battery of the Consortium to Establish a Registry of Alzheimer's Disease (CERAD). Thirty patients with clinical probable AD and 10 elderly healthy controls underwent (18)FDG brain PET imaging during a resting state. Correlations between metabolic values and cognitive measures were determined using a region of interest analysis with NEUROSTAT (University of Michigan, USA) and a voxel-based analysis with SPM96 (Wellcome Department, London, UK). Specific correlations were seen between measures …

MaleAgingmedicine.medical_specialtyNeuropsychological TestsAudiologyFunctional LateralityCognitionAlzheimer DiseaseFluorodeoxyglucose F18Image Processing Computer-AssistedmedicineHumansDementiaVerbal fluency testRegistriesNeuropsychological assessmentEpisodic memoryAgedBrain ChemistrySex Characteristicsmedicine.diagnostic_testResting state fMRIGeneral NeuroscienceNeuropsychologyCognitionMiddle Agedmedicine.diseaseGlucosePositron emission tomographyData Interpretation StatisticalPositron-Emission TomographyFemaleNeurology (clinical)RadiopharmaceuticalsGeriatrics and GerontologyPsychologyNeuroscienceDevelopmental BiologyNeurobiology of Aging
researchProduct

Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study.

2008

We investigated the influence of cell proportions and proliferation activities on tumor maximum standard uptake value (SUV(max)) in patients with squamous-cell esophageal cancer (SCEC).Sixteen (16) patients with untreated SCEC were examined with (18)F-flourodeoxyglucose positron emission tomography (FDG-PET). The tumor SUV(max) were calculated. Tumors were resected by transthoracic esophagectomy. Tissues were stained with hematoxylin and eosin for the measurement of cell proportions and MIB-1 for measurement of proliferation indices (PIs). Tumor SUV and histologic data were related by using multiple linear regression analysis.The mean proportion of tumor cells in the tumor site was 58.1% (+…

MaleCancer ResearchPathologymedicine.medical_specialtyEsophageal NeoplasmsCellH&E stainStandardized uptake valueFluorodeoxyglucose F18medicineCarcinomaHumansRadiology Nuclear Medicine and imagingAgedCell ProliferationCell SizePharmacologymedicine.diagnostic_testbusiness.industryFdg uptakeGeneral MedicineEsophageal cancerMiddle Agedmedicine.diseaseImmunohistochemistrymedicine.anatomical_structureOncologyPositron emission tomographyPositron-Emission TomographyCarcinoma Squamous CellMultiple linear regression analysisFemalebusinessCancer biotherapyradiopharmaceuticals
researchProduct

Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.

2003

Outcome of patients with metastatic disease mainly depends on accurate preoperative tumor staging. 18[F]fluorodeoxyglucose positron emission tomography (18F-PET) has been proven to be a valuable diagnostic tool in a number of different tumors but its direct influence on liver surgery has not been thoroughly investigated. Between July 1999 and March 2000, 50 consecutive patients with 174 suspected liver lesions were admitted to the University Hospital Jena. All 50 patients underwent abdominal ultrasound, CT-scan, and 18-FDG positron emission tomography scanning. In 23 patients the diagnostic work-up was completed by MRI scan. Altogether there were a total of 174 histologically proven intrahe…

MaleCancer Researchmedicine.medical_specialtyFluorine RadioisotopesLiver tumorCarcinoma HepatocellularBreast NeoplasmsSensitivity and SpecificityResectionAdenoma Liver CellFluorodeoxyglucose positron emission tomographyFluorodeoxyglucose F18Internal medicinemedicineHumansMri scanNeoplasm StagingHematologymedicine.diagnostic_testbusiness.industryUltrasoundLiver NeoplasmsGeneral Medicinemedicine.diseaseUniversity hospitalOncologyPositron emission tomographyFemaleRadiologyRadiopharmaceuticalsbusinessNuclear medicineColorectal NeoplasmsFollow-Up StudiesTomography Emission-ComputedJournal of cancer research and clinical oncology
researchProduct

Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the …

2015

Abstract Background and purpose We aimed to evaluate the patterns of loco-regional failure (LRF) after exclusive chemoradiotherapy (eCRT) for esophageal cancer with respect to planned dose and/or the incidental (unplanned) dose outside target volumes. Materials and methods Co-image registration of CT or 18 F-FDG PET-CT at the time of failure (tf) and at the time of CRT (t0) was performed in 34 patients with LRF. Dosimetric parameters with regard to local failure (LF), nodal failure (NF) and involved nodal stations (NS) were derived. Results Twenty-two patients (64.7%) had LF, the majority of which (95.5%) were located at the epicenter of the GTV of the primary tumor. The mean doses recalcul…

MaleEsophageal NeoplasmsDose distributionPlanned DoseFluorodeoxyglucose F18MedicineNon metastaticHumansRadiology Nuclear Medicine and imagingIn patientTreatment FailureAgedAged 80 and overbusiness.industryLocal failureRadiotherapy DosageHematologyChemoradiotherapyEsophageal cancerMiddle Agedmedicine.diseasePrimary tumorOncologyFemaleLymph NodesNeoplasm Recurrence LocalbusinessNuclear medicineTomography X-Ray ComputedChemoradiotherapyRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by (18)FDG-PET/CT

2017

Abstract Objectives The objective of this study was to investigate fludeoxyglucose F 18 positron emission tomography/computed tomography ( 18 FDG-PET/CT) parameters as predictive of response after stereotactic ablative radiotherapy (SABR) for lung oligometastases. Methods The inclusion criteria of the current retrospective study were as follows: (1) lung oligometastases treated by SABR, (2) presence of 18 FDG-PET/CT before and after SABR for at least two subsequent evaluations, (3) Karnofsky performance status higher than 80, and (4) life expectancy longer than 6 months. All patients were treated with a biologically equivalent dose of at least 100 Gy with an alpha/beta ratio of 10. The foll…

MaleFludeoxyglucose F-18Lung Neoplasmsmedicine.medical_treatment18FDG-PET/CT; Lung malignancies; Predictive factors; SABR; Adenocarcinoma; Aged; Aged 80 and over; Carcinoma Non-Small-Cell Lung; Carcinoma Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Radiosurgery; Oncology; Pulmonary and Respiratory MedicineSABR volatility model030218 nuclear medicine & medical imaging0302 clinical medicinePositron Emission Tomography Computed TomographyAblative case80 and overMedicineNon-Small-Cell LungSABRmedicine.diagnostic_test(18)FDG-PET/CTMiddle AgedPrognosisTumor Burdenmedicine.anatomical_structureLocalOncologyPositron emission tomography030220 oncology & carcinogenesisLymphatic MetastasisFemaleRadiologyPredictive factorsPulmonary and Respiratory Medicinemedicine.medical_specialtyLung malignanciesStandardized uptake value18FDG-PET/CTAdenocarcinomaRadiosurgery03 medical and health sciencesFluorodeoxyglucose F18HumansAgedNeoplasm StagingRetrospective StudiesLungbusiness.industryCarcinomaRetrospective cohort studyRadiation therapyNeoplasm RecurrenceSquamous CellRadiopharmaceuticalsbusinessNuclear medicineFollow-Up Studies(18)FDG-PET/CT; Lung malignancies; Predictive factors; SABR
researchProduct

Blood constituents trigger brain swelling, tissue death, and reduction of glucose metabolism early after acute subdural hematoma in rats

2009

Outcome from acute subdural hematoma is often worse than would be expected from the pure increase of intracranial volume by bleeding. The aim was to test whether volume-independent pathomechanisms aggravate damage by comparing the effects of blood infusion with those of an inert fluid, paraffin oil, on intracranial pressure (ICP), cerebral perfusion pressure (CPP), local cerebral blood flow (CBF), edema formation, glucose metabolism ([18F]-deoxyglucose, MicroPET), and histological outcome. Rats were injured by subdural infusion of 300 μL venous blood or paraffin. ICP, CPP, and CBF changes, assessed during the first 30 mins after injury, were not different between the injury groups at most …

MaleIntracranial PressureBlood PressureBrain EdemaCerebral edemaLesionRats Sprague-DawleyFluorodeoxyglucose F18medicineAnimalsHematoma Subdural AcuteCerebral perfusion pressureIntracranial pressureVascular diseasebusiness.industryVenous bloodmedicine.diseaseRatsBlood pressureGlucoseNeurologyCerebral blood flowParaffinAnesthesiaCerebrovascular CirculationPositron-Emission TomographyOriginal ArticleNeurology (clinical)medicine.symptomRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessEnergy Metabolism
researchProduct

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging☆

2008

Statistical comparisons of [(18)F]FDG PET scans between healthy subjects and patients with Alzheimer's disease (AD) or amnestic mild cognitive impairment (aMCI) using Statistical Parametric Mapping (SPM) usually require normalization of regional tracer uptake via ROIs defined using additional software. Here, we validate a simple SPM-based method for count normalization. FDG PET scans of 21 mild, 15 very mild AD, 11 aMCI patients and 15 age-matched controls were analyzed. First, we obtained relative increases in the whole patient sample compared to controls (i.e. areas relatively preserved in patients) with proportional scaling to the cerebral global mean (CGM). Next, average absolute counts…

MaleNormalization (statistics)Agingmedicine.medical_specialtyPathologyCognitive NeuroscienceLogistic regressionStatistical parametric mappingNeuroimagingAlzheimer DiseaseFluorodeoxyglucose F18Internal medicineImage Interpretation Computer-AssistedmedicineHumansDementiaHealthy agingRadionuclide ImagingCognitive impairmentAgedRetrospective StudiesBrain Mappingmedicine.diagnostic_testBrainmedicine.diseaseNeurologyPositron emission tomographyCardiologyFemaleCognition DisordersPsychologyAlgorithmsNeuroImage
researchProduct

Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18

2007

At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar healthy subjects. Scans normalized to the cerebral global mean (CGM), cerebellum (CBL), and the primary sensorimotor cortex (SMC). We evaluated the effect of the different count normalization procedures on the accuracy of (18)F-FDG PET to detect AD-specific metabolic abnormalities (voxel-based group comparison) and to differentiate between patient…

MaleNormalization (statistics)Pathologymedicine.medical_specialtyAdolescentNeuroscience (miscellaneous)Neuropsychological TestsStatistical parametric mappingGyrus CinguliSeverity of Illness IndexCentral nervous system diseaseAlzheimer DiseaseFluorodeoxyglucose F18CerebellumParietal LobemedicineHumansDementiaRadiology Nuclear Medicine and imagingAgedFluorodeoxyglucosemedicine.diagnostic_testbusiness.industryCognitive disorderMotor CortexSomatosensory Cortexmedicine.diseaseTemporal LobeFrontal LobePsychiatry and Mental healthPositron emission tomographyPositron-Emission TomographyFemaleRadiopharmaceuticalsAlzheimer's diseaseCognition DisordersNuclear medicinebusinessPsychologymedicine.drugPsychiatry Research: Neuroimaging
researchProduct

Validating the DemTect with 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography as a Sensitive Neuropsychological Screening Test for Early Alzheim…

2005

<i>Objectives:</i> The first study to validate the diagnostic value of the DemTect, a short neuropsychological screening test for dementia (8–10 min), using 18-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) in patients of a memory clinic. <i>Methods:</i> DemTect results were compared to the clinical diagnosis and to FDG-PET as a reference method for the early in vivo detection of Alzheimer’s disease (AD). <i>Results:</i> 38 patients (age 65.2 ± 9.8 years, 16 men, 22 women) were investigated using clinical standard examination, FDG-PET, and cranial magnetic resonance imaging. According to NINCDS-ADRDA and Petersen’s criteria, 18 patients had…

MalePathologymedicine.medical_specialtyCognitive NeuroscienceNeuropsychological TestsCognitionAlzheimer DiseaseFluorodeoxyglucose F18MemorymedicineHumansDementiaAgedmedicine.diagnostic_testbusiness.industryCognitive disorderMemory clinicNeuropsychologyInfarction Middle Cerebral ArteryMagnetic resonance imagingNeuropsychological testMiddle Agedmedicine.diseasePsychiatry and Mental healthROC CurvePositron emission tomographyData Interpretation StatisticalPositron-Emission TomographyMental RecallFemaleRadiopharmaceuticalsGeriatrics and GerontologyAlzheimer's diseasePsychologyNuclear medicinebusinessDementia and Geriatric Cognitive Disorders
researchProduct